Selected References
- Committee on Drugs. American Academy of Pediatrics. 2001. The transfer of drugs and other chemicals into human milk. Pediatrics 108:776-789.
- Cossette, B. et al. (2014). Relative perinatal safety of salmeterol vs formoterol and fluticasone vs budesonide use during pregnancy. Annals of Allergy, Asthma & Immunology, 112(5), 459–464.
- Eltonsy, S. et al. (2011). Beta2-agonists use during pregnancy and the risk of congenital malformations. Birth Defects Research Part A: Clinical and Molecular Teratology, 91(11), 937–947
- Gregersen TL and Ulrik CS. (2013) Safety of bronchodilators and corticosteroids for asthma during pregnancy: what we know and what we need to do better. J Asthma Allergy. 6: 117–125.
- Lim, A., Abramson, MJ. (2013). Asthma Drugs in pregnancy and lactation. Australian Prescriber, 36(5), 150–153.
- Lim, A. et al. (2011). Systematic Review of the Safety of Regular Preventive Asthma Medications During Pregnancy, 931-945
- Namazy, J., & Schatz, M. (2018). Management of Asthma during Pregnancy: Optimizing Outcomes and Minimizing Risk. Seminars in Respiratory and Critical Care Medicine, 39(01), 029–035.
- National Asthma Education and Prevention Program. Working Group. 2004. Report on managing asthma during pregnancy: Recommendations for pharmacologic treatment. Update 2004. NIH publication NO.05-5236. Bethesda, MD: US Department of Health and Human Services; National Institutes of Health; National Heart, Lung and Blood Institute.
- Tamasi L, et al. 2005. The management of bronchial asthma during pregnancy – Hungarian experiences. Orv Hetil. 146(45):2035-2039.
- Wilton LV and Shakir SA. 2002. A postmarketing surveillance study of formoterol (Foradil). Its use in general practice in England. Drug Saf 25:213-223.
